Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
We investigated whether circulating osteopontin (OPN) could be used as a biomarker for cervical cancer. We employed a monoclonal antibody (mAb 659) specific for the unique and intact thrombin-sensitive site in OPN using an inhibition ELISA. We found significantly higher levels of OPN in 33 cervical...
Autors principals: | , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Public Library of Science (PLoS)
2016-01-01
|
Col·lecció: | PLoS ONE |
Accés en línia: | http://europepmc.org/articles/PMC4975440?pdf=render |